# Coronavirus (COVID-19) ACEi/ARB Investigation

> **NCT04330300** · PHASE4 · SUSPENDED · sponsor: **National University of Ireland, Galway, Ireland** · enrollment: 2414 (estimated)

## Conditions studied

- Hypertension
- COVID-19

## Interventions

- **DRUG:** Thiazide or Thiazide-like diuretics
- **DRUG:** Calcium Channel Blockers
- **DRUG:** ACE inhibitor
- **DRUG:** Angiotensin receptor blocker

## Key facts

- **NCT ID:** NCT04330300
- **Lead sponsor:** National University of Ireland, Galway, Ireland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-04-30
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-12-01
- **Target enrollment:** 2414 (ESTIMATED)
- **Why stopped:** Challenges with funding and very low incidence of COVID-19 at Irish study site
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04330300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04330300, "Coronavirus (COVID-19) ACEi/ARB Investigation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04330300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*